Filters

Alcelaphine herpesvirus 1 Putative apoptosis regulator A9 (A9)

Alcelaphine herpesvirus 1 Putative apoptosis regulator A9 (A9) size: 1000ug 1487

Supplier MBS RECOMBINANT PROTEINS
Price 1487
Size 1000ug
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
Long nameRecombinant Alcelaphine herpesvirus 1 Putative apoptosis regulator A9 (A9)
Alternative names A9, Putative apoptosis regulator A9, contains only conserved BH1 domain, similar to Bcl-family of proteins, A9
Gene nameN/A
Other gene names A9, AlHV1gp70
General description All of our recombinant proteins are manufactured in strictly controlled facilities and by using a well established technology which guarantees full batch-to-bact consistency and experiment reproducibility, The protein can be with or without a His-Tag or other tag in accordance to customer's request, coli, Putative apoptosis regulator A9 (A9) is a recombinant protein expressed in E
Product categoryRecombinant Proteins
Expression system coli, E
Available also expressed in: Yeast, E Coli
PurityGreater than 90% (determined by SDS-PAGE)
Form We can custom produce according to your specifications, This item requires custom production and lead time is between 5-9 weeks
Storage Avoid cycles of freezing and thawing as they might denaturate the polypeptide chains, For extended periods of time it is recommended to keep the protein frozen at -40 or -80 degrees Celsius, This protein can be stored at -20 degrees Celsius
Applications IFA, RIA, Western Blot, etc, This protein can be used as a positive control for applications such as ELISA
DescriptionThis 1 is suited for programmed cell-death studies
Gene targetAlcelaphine herpesvirus 1 Putative regulator A9 (A9)
Short nameAlcelaphine herpesvirus 1 Putative apoptosis regulator A9 (A9)
Technique apoptosis pathway, apoptosis
Alternative nameAlcelaphine herpesvirus 1 Putative programmed cellular destruction regulator A9 (A9)
Alternative techniquecelldeath

Similar products

Subscribe to our Newsletter